USPH
U.S. Physical Therapy Inc
Price:  
104.62 
USD
Volume:  
88,812.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

USPH EV/EBITDA

-57.1%
Upside

As of 2024-03-02, the EV/EBITDA ratio of U.S. Physical Therapy Inc (USPH) is 18.74. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. USPH's latest enterprise value is 1,569.65 mil USD. USPH's TTM EBITDA according to its financial statements is 83.77 mil USD. Dividing these 2 quantities gives us the above USPH EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 3.3x - 11.0x 7.2x
Forward P/E multiples 8.4x - 12.3x 9.1x
Fair Price 18.46 - 67.61 44.85
Upside -82.4% - -35.4% -57.1%
104.62 USD
Stock Price
44.85 USD
Fair Price

USPH EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-03-01 18.74
2024-02-29 19.03
2024-02-28 17.89
2024-02-27 18.41
2024-02-26 18.07
2024-02-23 18.27
2024-02-22 18.30
2024-02-21 18.19
2024-02-20 18.29
2024-02-16 18.22
2024-02-15 17.57
2024-02-14 17.21
2024-02-13 16.68
2024-02-12 17.32
2024-02-09 17.16
2024-02-08 16.81
2024-02-07 16.80
2024-02-06 16.79
2024-02-05 16.67
2024-02-02 16.90
2024-02-01 16.95
2024-01-31 16.53
2024-01-30 17.24
2024-01-29 17.16
2024-01-26 16.86
2024-01-25 16.91
2024-01-24 16.82
2024-01-23 16.82
2024-01-22 16.98
2024-01-19 16.74
2024-01-18 16.81
2024-01-17 16.62
2024-01-16 17.13
2024-01-12 16.95
2024-01-11 17.06
2024-01-10 16.97
2024-01-09 16.78
2024-01-08 16.89
2024-01-05 16.62
2024-01-04 16.72
2024-01-03 16.54
2024-01-02 16.74
2023-12-29 16.68
2023-12-28 17.03
2023-12-27 17.07
2023-12-26 17.14
2023-12-22 16.94
2023-12-21 16.84
2023-12-20 16.66
2023-12-19 16.55